Ataxia-telangiectasia-like disorder is a rare genetic condition that affects movement and coordination. People with Ataxia-telangiectasia-like disorder often develop unsteady walking, slurred speech, and coordination problems in childhood or the teen years. The condition is lifelong, and features can slowly worsen over time. Not everyone will have the same experience, and life expectancy can be near typical when infections and complications are managed. Treatment focuses on supportive care like physical and speech therapy, help with school and daily activities, and monitoring for infections or neurologic changes.
Overview
Ataxia-telangiectasia-like disorderSymptoms
Ataxia-telangiectasia-like disorder features early childhood onset of unsteady gait, poor coordination, and slurred speech. Many also have trouble moving their eyes quickly and with fine hand movements. Some experience frequent infections or neuropathy; cancer risk may increase, and progression varies.
Outlook and prognosis
Most people with Ataxia‑telangiectasia‑like disorder develop slowly progressive balance and coordination problems, often beginning in childhood or adolescence. Thinking and sensation are usually preserved, and life span can be near typical. Regular physiotherapy, fall‑prevention, and tailored supports help maintain independence.
Causes and risk factors
Caused by inherited changes in the MRE11 gene; autosomal recessive. Risk rises when both parents are carriers, especially in consanguineous families. People with ataxia-telangiectasia-like disorder are highly sensitive to ionizing radiation; infections and poor nutrition may worsen complications.
Genetic influences
Genetics is central in Ataxia-telangiectasia-like disorder, which is caused by inherited changes in the MRE11 gene. Most cases follow an autosomal recessive pattern. Different variants can influence age at onset, symptom severity, and progression.
Diagnosis
Doctors suspect ataxia-telangiectasia-like disorder based on progressive coordination problems and exam findings. Genetic diagnosis of ataxia-telangiectasia-like disorder is confirmed with genetic tests, supported by brain MRI and lab results.
Treatment and drugs
Treatment for ataxia‑telangiectasia‑like disorder focuses on easing movement problems, protecting balance, and supporting daily activities. Care often includes physiotherapy, occupational therapy, speech and swallow support, targeted symptom medicines, and fall‑prevention strategies. Regular check‑ins with neurology and genetics guide adjustments over time.
Symptoms
Families often first spot unsteady walking, slower eye movements, or slurred speech during childhood, especially when running, reading across a page, or trying to speak quickly. Early features of Ataxia-telangiectasia-like disorder center on balance, coordination, and eye control. Features vary from person to person and can change over time. It is lifelong and mainly affects movement and eye control rather than thinking skills.
Steps can look wide-based and unsteady, with more frequent stumbles. Running, quick turns, and stairs can feel less secure.
Trouble starting quick eye movements between objects, especially side to side. In medical terms, this is oculomotor apraxia; in everyday life, it shows up as head turns or extra blinks to shift gaze.
Fine tasks like buttoning, handwriting, or using utensils can be slower and less precise. Cups may spill, and small objects can be harder to handle.
Speech can sound slow or slurred, especially when tired or under pressure. In Ataxia-telangiectasia-like disorder, this often reflects reduced coordination of the mouth and tongue.
How people usually first notice Ataxia-telangiectasia-like disorder?
Many families first notice something is off when a child starts walking later than peers or seems unusually unsteady, with frequent falls, clumsiness, or shaky, poorly coordinated movements that don’t match their age. Doctors may also pick up early eye-movement problems (trouble tracking or quick “jerky” eye shifts), slurred or nasal-sounding speech, or subtle hand coordination issues during routine exams, which raises concern for the first signs of ataxia-telangiectasia-like disorder. Unlike classic ataxia-telangiectasia, visible “spider vein” telangiectasias on the eyes or skin are often absent early on, so the condition is usually first noticed because of progressive balance and coordination difficulties in early childhood.
Types of Ataxia-telangiectasia-like disorder
Ataxia-telangiectasia-like disorder (ATLD) has a few recognized genetic variants, and each can shape how early symptoms start and how fast they change over time. The main differences relate to which DNA-repair gene is affected and whether both copies are fully disrupted or only partly working. People may notice different sets of symptoms depending on their situation. When reading about types of ATLD, you’ll see that movement and coordination issues are common across variants, but the timing, severity, and added features can vary.
MRE11-related ATLD
This variant is caused by changes in the MRE11 gene, part of a DNA-repair complex. Symptoms often start in later childhood with unsteady walking and coordination troubles. Eye-movement difficulties and slow progression are common compared with classic ataxia-telangiectasia.
NBN-related ATLD
Changes in the NBN gene can produce an ATLD-like picture with coordination problems and mild learning impacts. People with this variant may have fewer infections and less obvious telangiectasias than in classic A‑T. The course may be milder, but this can vary.
RAD50-related ATLD
Variants in RAD50, another partner in the same repair complex, are a rare cause. Symptoms may include gait ataxia, balance issues, and slowed saccades, with onset from childhood to adolescence. Because it is uncommon, recognized features come mainly from small case series.
Hypomorphic variants
These are changes that reduce but don’t eliminate gene function in MRE11, NBN, or RAD50. Symptoms may appear later and progress more slowly, with milder coordination issues. Not everyone will experience every type of related feature.
Classic A‑T comparison
While not a type of ATLD, clinicians often compare variants of ATLD to classic ataxia‑telangiectasia to explain differences. ATLD types of variants typically lack prominent telangiectasias and have fewer immune problems. Cancer risk patterns and severity can also differ.
What genetics can tell you about symptoms
Some people with ataxia‑telangiectasia‑like disorder have changes in the MRE11 gene that disrupts a cell’s DNA repair “dimmer switch,” leading to early‑onset balance and coordination problems (ataxia) and slow eye movements. Certain variants can also cause nerve damage in hands and feet, tremor, and speech difficulties.
Causes and risk factors
Ataxia-telangiectasia-like disorder is caused by inherited changes in the MRE11A gene that impair DNA repair. It is usually autosomal recessive, so a child is affected when both parents carry one changed copy. Key risk factors for Ataxia-telangiectasia-like disorder include having carrier parents, and the chance is higher when parents are related by blood. Exposure to ionizing radiation can worsen DNA damage in people with Ataxia-telangiectasia-like disorder, so doctors try to limit unnecessary scans and certain treatments. Doctors distinguish between risk factors you can change and those you can’t, and healthy routines and avoiding smoking or heavy alcohol may help lower complications.
Environmental and biological risk factors
Ataxia-telangiectasia-like disorder is rare, and outside of what you are born with, few clear environmental or biological factors have been shown to raise the chance of it occurring. Doctors often group risks into internal (biological) and external (environmental). Based on current evidence, most common exposures in pregnancy or around conception are not known to cause this condition. In short, environmental and biological risk factors for ataxia-telangiectasia-like disorder appear limited and not well established.
In many conditions, older egg or sperm age slightly raises the chance of new changes at conception. For ataxia-telangiectasia-like disorder, research has not shown a clear link, and any effect—if present—seems very small.
Large exposures to ionizing radiation can damage reproductive cells. No studies show a specific increase in ataxia-telangiectasia-like disorder, but avoiding unnecessary high-dose exposure is sensible.
Exposure to lead, mercury, or certain solvents can affect fertility or pregnancy. These exposures have not been shown to increase the chance of ataxia-telangiectasia-like disorder.
Conditions like uncontrolled diabetes or thyroid disease can raise risks for some birth problems. They are not known to cause ataxia-telangiectasia-like disorder.
Genetic risk factors
In Ataxia-telangiectasia-like disorder (ATLD), the underlying cause is usually two inherited changes in the MRE11 gene, which helps repair broken DNA. Some risk factors are inherited through our genes. Because this gene affects brain cells that guide balance and eye movements, early symptoms of Ataxia-telangiectasia-like disorder often appear in childhood. Genetic testing can confirm the cause and show who in a family may be a carrier.
MRE11 gene variants: Two harmful changes (one from each parent) in the MRE11 gene are the known genetic cause of Ataxia-telangiectasia-like disorder. This gene makes a protein that helps repair breaks in DNA. When it does not work well, nerve cells that control balance and eye movements can be more vulnerable.
Autosomal recessive inheritance: ATLD develops when a child inherits one non-working MRE11 copy from each parent. Carriers usually have no symptoms. Each pregnancy has a 25% (1 in 4) chance of an affected child when both parents are carriers.
Family history carriers: Having close relatives who carry an MRE11 change raises the chance that a child could inherit ATLD. Unaffected siblings of someone with ATLD have a 2 in 3 chance to be carriers. Carrier testing in relatives can clarify personal risk.
Variant effect differences: Different MRE11 changes can leave the protein with more or less function. This can influence the age when symptoms start and how quickly problems progress. Even within one family, severity can vary.
Lifestyle risk factors
Ataxia-telangiectasia-like disorder is a genetic condition, so lifestyle habits do not cause it. However, daily choices can influence how symptoms progress, how safely you move, and how well complications are prevented. Understanding how lifestyle affects Ataxia-telangiectasia-like disorder helps target the areas where habits can ease coordination problems, fatigue, and nutrition challenges. Below are practical lifestyle elements linked directly to symptom control and day-to-day function.
Consistent, low-impact exercise helps maintain strength and endurance that support gait in Ataxia-telangiectasia-like disorder. Supervised balance and coordination work can slow deconditioning and reduce fall risk.
Task-specific balance, core, and coordination drills can improve steadiness and shorten recovery time after stumbles. Using supports (bars, harnesses, water) allows practice without added injury risk.
Progressive resistance training preserves muscle power needed for transfers and walking. Stronger limb and trunk muscles can compensate for cerebellar incoordination during daily tasks.
Gentle stretching and posture work help prevent stiffness that worsens gait mechanics. Upright alignment can also make breathing and swallowing more efficient.
Risk prevention
Ataxia-telangiectasia-like disorder is an inherited condition, so you can’t fully prevent the condition itself. Prevention focuses on lowering complications, staying mobile, and avoiding triggers that add extra strain on the body. Prevention is about lowering risk, not eliminating it completely. Working with your care team can help tailor steps to your age, symptoms, and family situation.
If ATLD runs in your family, genetic counseling can explain carrier testing and options for future pregnancies. Some families consider preimplantation or prenatal testing when planning children.
People with ataxia-telangiectasia-like disorder can be more sensitive to ionizing radiation from CT scans or X‑rays. Tell every healthcare provider so imaging can be minimized or replaced with MRI when appropriate.
Routine vaccinations, including flu and pneumonia shots, help prevent infections that can hit harder if swallowing or cough strength are reduced. Your doctor can confirm which vaccines are right for you.
Regular physical therapy helps maintain strength, coordination, and walking safety. Home changes like grab bars, good lighting, and non-slip shoes can lower fall risk.
Transmission
Ataxia-telangiectasia-like disorder is not contagious; you can’t catch it or pass it through coughing, touch, sex, or breastfeeding. It is inherited in an autosomal recessive way, meaning a child needs to receive two nonworking copies of the gene—one from each parent—to develop the condition. When both parents are healthy carriers, each pregnancy has a 25% (1 in 4) chance of a child with Ataxia-telangiectasia-like disorder, a 50% (1 in 2) chance of a carrier, and a 25% chance of neither.
Most people with Ataxia-telangiectasia-like disorder inherited it from carrier parents; new, spontaneous gene changes are possible but uncommon. If you’re wondering about how Ataxia-telangiectasia-like disorder is inherited, a genetics professional can explain risks and testing options for relatives.
When to test your genes
Consider genetic testing if you have progressive coordination problems (ataxia), unexplained slowed eye movements, or a family history of similar neurologic symptoms. Test sooner if symptoms begin in childhood or you’re planning a family, as results can guide surveillance and reproductive options. Ask your clinician about APTX/APTXL testing and referral to genetics.
Diagnosis
For many, the first step comes when everyday activities like running in the playground or copying at school start feeling harder because of shaky balance or slow eye movements. Ataxia-telangiectasia-like disorder is usually suspected when these patterns show up in childhood and gradually progress. Doctors confirm what they see with a combination of exams, imaging, and genetic tests. Genetic testing may be offered to clarify risk or guide treatment.
Providers look for a gradual, childhood-onset loss of coordination (ataxia), frequent falls, and trouble with fine motor tasks. Slow or difficult eye movements can be another early clue. These patterns help guide the diagnosis of Ataxia-telangiectasia-like disorder.
The exam checks balance, walking, reflexes, and coordination with simple bedside tests. Subtle signs, like difficulty with heel-to-toe walking, can support a suspected diagnosis.
Doctors assess how the eyes start and track movements, looking for delayed starts or head thrusts that compensate. These findings, sometimes called oculomotor apraxia, are common in related ataxia conditions.
Imaging often shows shrinkage of the cerebellum, the part of the brain that coordinates movement. This pattern supports the clinical picture and helps rule out other causes of ataxia.
Stages of Ataxia-telangiectasia-like disorder
Ataxia-telangiectasia-like disorder does not have defined progression stages. Symptoms can change slowly over time and vary from person to person, so there isn’t a standard “stage 1, 2, 3” framework. Different tests may be suggested to help confirm the cause and rule out similar conditions. Diagnosis usually brings together the story of early symptoms of ataxia-telangiectasia-like disorder (such as unsteady walking in childhood or trouble coordinating eye movements), a neurological exam, brain MRI, and genetic testing to look for changes linked to this condition.
Outlook and prognosis
Looking ahead can feel daunting, but most people with Ataxia-telangiectasia-like disorder see symptoms unfold slowly over many years. Balance and coordination problems often begin in childhood or the teen years and progress at a measured pace, which can affect walking, handwriting, and tasks that require fine control. Many people find that symptoms change gradually rather than suddenly, with long stretches where abilities feel stable before new challenges appear.
Doctors call this the prognosis—a medical word for likely outcomes. For many living with Ataxia-telangiectasia-like disorder, life expectancy is near typical, because serious immune problems and a high cancer risk are not hallmark features the way they are in classic ataxia-telangiectasia. That said, falls, swallowing difficulties, or respiratory infections can add risk over time, so prevention and early treatment matter. Early care can make a real difference, including physical and occupational therapy, speech and swallow support, and tools that make daily life safer.
Some people experience early symptoms of Ataxia-telangiectasia-like disorder in late childhood, while others notice issues only in adulthood, which partly explains the wide range of long-term outcomes. Mobility often shifts from independent walking to using a cane, walker, or wheelchair over years, not months. With ongoing care, many people maintain meaningful independence at home, school, and work, adapting routines as needed and planning around energy levels and balance. Talk with your doctor about what your personal outlook might look like, including ways to prevent complications and how often to check in as needs change.
Long-term effects
For many living with Ataxia-telangiectasia-like disorder, the long view centers on how movement and coordination change over time. Early symptoms of Ataxia-telangiectasia-like disorder often involve balance and eye-movement control, with walking and reading becoming more effortful. Long-term effects vary widely, but most people see a slow progression from unsteady walking to needing mobility aids. Cancer risk and immune problems are usually much lower than in classic ataxia-telangiectasia, and many live into adulthood with thinking and learning largely intact.
Balance and coordination gradually worsen over years. Many move from unsteady walking to using a wheelchair for distance. Day-to-day safety and independence can shift as mobility changes.
Difficulty starting or coordinating eye movements can make tracking text or moving objects hard. People may turn their head to compensate for the eyes not shifting quickly. Reading can take longer and feel tiring.
Speech may become slower and slurred over time. Listeners might notice words blending together. Conversations in noisy settings can feel more challenging.
Some develop trouble coordinating swallowing, which can lead to coughing during meals. This raises the risk of food or liquid going down the wrong way. Weight changes can follow if eating becomes effortful.
How is it to live with Ataxia-telangiectasia-like disorder?
Living with ataxia‑telangiectasia–like disorder often means planning around balance and coordination challenges: walking on uneven ground, writing by hand, or tasks that require fine motor control can take more time and extra focus, and falls may be more common. Fatigue can build after routine activities, so pacing, using adaptive tools, and physical or occupational therapy become practical supports that preserve independence. People around you—family, friends, teachers, coworkers—may need to adjust expectations, offer a steady arm on stairs, allow extra time, and keep spaces uncluttered to reduce tripping risks, but most find that clear communication makes these changes straightforward. Many living with the condition build reliable routines and safety habits that keep daily life active, social, and meaningful, even if the route there is a little slower.
Treatment and drugs
Treatment for ataxia‑telangiectasia–like disorder focuses on easing symptoms, protecting nerve function, and preventing complications, since there’s currently no cure. Doctors may recommend physical and occupational therapy to maintain balance, strength, and daily function, along with speech therapy if coordination affects swallowing or speech. Medicines that ease symptoms are called symptomatic treatments, and may include options to reduce tremor or muscle stiffness, plus targeted therapies for nerve pain if present. Because infections and fatigue can worsen early symptoms of ataxia‑telangiectasia–like disorder, care teams often include plans for vaccinations, nutrition, and fall prevention, and they may monitor for immune or lung issues. Not every treatment works the same way for every person, so your doctor can adjust the plan over time and may coordinate genetic counseling and specialist follow‑up.
Non-drug treatment
Living with Ataxia-telangiectasia-like disorder often means adjusting day-to-day routines to stay mobile, safe, and connected. Alongside medicines, non-drug therapies can help preserve function, reduce complications, and support independence. Care plans are tailored, since symptoms can vary and change slowly over time. Many people do best with a coordinated team approach focused on movement, communication, nutrition, and practical supports.
Targeted balance, strength, and coordination exercises help steady walking and reduce falls. Starting even when early symptoms of Ataxia-telangiectasia-like disorder appear may slow loss of mobility. Programs are adapted over time as needs change.
Skills training and home adaptations make everyday tasks like dressing and cooking easier and safer. Therapists can suggest tool grips, bathroom rails, and energy-saving techniques. This supports independence at home and work.
Exercises and pacing strategies can improve slurred speech and voice clarity. Swallowing assessments help prevent choking and aspiration. Texture changes or thickened liquids may make eating and drinking safer.
A dietitian can tailor meals to maintain weight and muscle while accommodating swallowing needs. High-calorie, nutrient-dense options may help if eating takes longer. Supplemental shakes or feeding plans are considered if intake drops.
Your genes may have an impact on how drugs work for you
Medicines for ataxia‑telangiectasia–like disorder can work differently depending on genes that affect how the body processes drugs and repairs DNA. Genetic testing may guide dose, reduce side effects, and help clinicians choose supportive treatments more safely.
Pharmacological treatments
People living with ataxia-telangiectasia-like disorder (ATLD) don’t have a single medicine that treats the root cause yet. When medications for ataxia-telangiectasia-like disorder are used, they focus on easing day-to-day symptoms like tremor, stiffness, mood changes, or nerve pain. Not everyone responds to the same medication in the same way. Doctors tailor choices to your symptoms, other health issues, and side-effect tolerance.
This beta blocker can lessen action tremor that interferes with eating, writing, or using a phone. It may cause low blood pressure or fatigue, so monitoring is important.
This antiseizure medicine is another option for disabling tremor in ATLD. It is started low and increased slowly to limit dizziness or sleepiness.
This muscle relaxant can ease spasticity and painful muscle cramps. For some with ATLD, it improves walking comfort and reduces falls.
This alternative to baclofen can reduce stiffness and nighttime spasms. It can make you drowsy and may affect liver tests, so dosing is adjusted carefully.
Genetic influences
Ataxia-telangiectasia-like disorder usually arises when a child inherits two altered copies of the same gene, one from each parent. In many families, the gene involved is called MRE11, which helps cells fix everyday DNA damage; when it doesn’t work properly, brain areas that guide balance and movement can be affected. Parents who each carry one copy typically have no symptoms, but with every pregnancy there is a 25% (1 in 4) chance their child will have Ataxia-telangiectasia-like disorder. A “carrier” means you hold the gene change but may not show symptoms. Genetic testing can look for changes in MRE11 and related DNA-repair genes to confirm the condition, clarify the chance of the condition in future pregnancies, and guide testing for siblings, especially if early symptoms of Ataxia-telangiectasia-like disorder appear. Severity and age of onset can still differ widely in people with the condition, even within the same family, so meeting with a genetics professional can help interpret results and plan next steps.
Is Ataxia-telangiectasia-like disorder genetic?
Genetics is central in Ataxia-telangiectasia-like disorder, which is caused by inherited changes in the MRE11 gene. Most cases follow an autosomal recessive pattern. Different variants can influence age at onset, symptom severity, and progression.
Pharmacogenetics—how genetics influence drug effects
Changes in a DNA‑repair gene (most often MRE11) in Ataxia‑telangiectasia–like disorder can make cells much more sensitive to treatments that damage DNA, including radiation therapy and some chemotherapy drugs. Because of this drug sensitivity in Ataxia‑telangiectasia–like disorder, doctors usually avoid ionizing radiation when possible and choose medicines that are less likely to cause double‑strand DNA breaks, or they use lower doses with close monitoring. Genetic testing can sometimes identify how your body may respond to certain treatments, helping tailor safer options. This sensitivity also influences imaging choices, so teams often favor MRI or ultrasound over CT scans or other tests that use radiation when it’s reasonable to do so. These DNA‑repair changes do not generally alter how the liver processes everyday medicines, but separate, common pharmacogenetic differences unrelated to ATLD can still affect response to pain relievers, antidepressants, and other drugs. If cancer treatment is needed, specialists familiar with the ataxia‑telangiectasia spectrum plan regimens that minimize DNA‑damage exposure and build in extra checks for side effects.
Interactions with other conditions
People living with Ataxia-telangiectasia-like disorder (ATLD) often notice that common illnesses interact with their neurologic symptoms. A chest cold or stomach virus can temporarily worsen balance, coordination, and eye-movement control; in other words, a condition may “exacerbate” (make worse) symptoms of another. Because ATLD involves a DNA repair problem, there’s heightened sensitivity to ionizing radiation, so frequent CT scans or certain cancer treatments that rely on radiation or strong DNA-damaging drugs may carry extra risk and need careful planning. Some studies suggest a modestly increased cancer risk in ATLD, so if cancer does occur, teams usually choose therapies that limit radiation exposure and adjust doses to reduce side effects.
If there’s any degree of immune weakness, respiratory infections can be more frequent, which can in turn amplify gait instability; even early symptoms of Ataxia-telangiectasia-like disorder like unsteady walking may flare during infections. ATLD can coexist with other neurologic conditions (for example, neuropathy), and overlapping features may make it harder to tell which issue is driving new changes day to day. Talk with your doctor about how your conditions may influence each other, including imaging choices, vaccine schedules, and which medications are safest if you ever need cancer treatment.
How genes can cause diseases
Humans have more than 20,000 genes, each carrying out one or a few specific functions in the body. One gene instructs the body to digest lactose from milk, another tells the body how to build strong bones and another prevents the body's cells from beginning to multiply uncontrollably and developing into cancer. As all of these genes combined are the building instructions for our body, a defect in one of these genes can have severe health consequences.
Through decades of genetic research, we know the genetic code of any healthy/functional human gene. We have also identified that in certain positions on a gene, some individuals may have a different genetic letter from the one you have. We call these hotspots "Genetic Variations" or "Variants" in short. In many cases, studies have been able to show that having the genetic letter "G" in the position makes you healthy, but having the letter "A" in the same position disrupts the gene function and causes a disease. Genopedia allows you to view these variants in genes and summarizes all that we know from scientific research, which genetic letters (Genotype) have good or bad consequences on your health or on your traits.
History
Throughout history, people have described children who developed unsteady walking and, later, trouble with coordination that didn’t match early milestones. Families and communities once noticed patterns: a child who stumbled more than peers, or a teen who needed railings sooner than friends. Doctors noted these stories long before modern testing could explain them.
First described in the medical literature as a condition resembling ataxia-telangiectasia, early reports focused on the gradual loss of balance and coordination, with fewer of the eye and skin blood-vessel changes seen in classic ataxia‑telangiectasia. From these first observations, clinicians grouped these cases together because the day-to-day challenges looked similar—frequent falls, slurred speech developing over time, and trouble with fine hand movements—even if some hallmark features were missing.
As medical science evolved, careful neurological exams and brain imaging showed patterns consistent with cerebellar involvement, the part of the brain that fine-tunes movement. Initially understood only through symptoms, later studies noticed that some families had more than one affected child, hinting at an inherited cause. In recent decades, knowledge has built on a long tradition of observation, and advances in genetics confirmed that ataxia-telangiectasia-like disorder shares pathways with classic ataxia‑telangiectasia but differs in key genes and in how quickly symptoms progress.
Over time, descriptions became more precise. Researchers recognized that many people with ataxia-telangiectasia-like disorder do not have the immune problems or high cancer risk typically seen in classic ataxia‑telangiectasia, and that movement symptoms often begin in later childhood or adolescence rather than early toddler years. These historical steps helped separate look‑alike conditions and gave families clearer expectations about testing, prognosis, and supportive care.
Despite evolving definitions, the purpose has stayed the same: to connect observed symptoms with underlying biology so care can be better tailored. Knowing the condition’s history helps explain why some adults were once told they had “unspecified ataxia,” only to receive a more accurate diagnosis once genetic testing became available. Today, the story of ataxia-telangiectasia-like disorder reflects steady progress—from bedside observations to lab discoveries—so people living with the condition can get clearer answers earlier in life.